456 related articles for article (PubMed ID: 15064358)
1. The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival.
Pritzker LB; Scatena M; Giachelli CM
Mol Biol Cell; 2004 Jun; 15(6):2834-41. PubMed ID: 15064358
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm.
Lonergan M; Aponso D; Marvin KW; Helliwell RJ; Sato TA; Mitchell MD; Chaiwaropongsa T; Romero R; Keelan JA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3835-44. PubMed ID: 12915677
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
Shipman CM; Croucher PI
Cancer Res; 2003 Mar; 63(5):912-6. PubMed ID: 12615702
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.
Emery JG; McDonnell P; Burke MB; Deen KC; Lyn S; Silverman C; Dul E; Appelbaum ER; Eichman C; DiPrinzio R; Dodds RA; James IE; Rosenberg M; Lee JC; Young PR
J Biol Chem; 1998 Jun; 273(23):14363-7. PubMed ID: 9603945
[TBL] [Abstract][Full Text] [Related]
6. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
[TBL] [Abstract][Full Text] [Related]
7. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
9. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation.
Chen PL; Easton A
J Vasc Res; 2008; 45(2):111-22. PubMed ID: 17940338
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells.
Miyashita T; Kawakami A; Nakashima T; Yamasaki S; Tamai M; Tanaka F; Kamachi M; Ida H; Migita K; Origuchi T; Nakao K; Eguchi K
Clin Exp Immunol; 2004 Aug; 137(2):430-6. PubMed ID: 15270863
[TBL] [Abstract][Full Text] [Related]
13. TRAIL induces death of human oligodendrocytes isolated from adult brain.
Matysiak M; Jurewicz A; Jaskolski D; Selmaj K
Brain; 2002 Nov; 125(Pt 11):2469-80. PubMed ID: 12390973
[TBL] [Abstract][Full Text] [Related]
14. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
[TBL] [Abstract][Full Text] [Related]
16. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.
Schoppet M; Al-Fakhri N; Franke FE; Katz N; Barth PJ; Maisch B; Preissner KT; Hofbauer LC
J Clin Endocrinol Metab; 2004 Aug; 89(8):4104-12. PubMed ID: 15292354
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
18. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
19. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
